Latest news
Loading news…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Jerusalem, Yerushalayim, Israel
Key People at Splisense
CEO
7
professional contacts at Splisense
Contact execs at Splisense →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Splisense
Loading news…
FAQs about Splisense
People who checked this page also checked these
Browse the full Acquirezy directory.